Moderna, IAVI to commence Phase I trial of mRNA HIV vaccine trial in Africa
The Phase I trial will analyse for safety and immunogenicity of the mRNA HIV vaccine antigen in African populations.

The Phase I trial will analyse for safety and immunogenicity of the mRNA HIV vaccine antigen in African populations.
The CRO will carry out data and statistical assessment to determine the relative risks of Covid-19 and severe disease.
Two clinical trials will be conducted in the US and South Africa to assess intranasal doses of IGM-6268.
Over the last five years, the conduct of clinical research in Africa has shown a steady increase, but the level…
ByThe trial will assess the tolerability, safety, efficacy and PK of two varying doses of suramin in adult LCS patients.
The gaping inequity in global vaccination rates only ensures that new Covid-19 variants such as Omicron will continue to emerge.
ByCovid-19 vaccine investigator Shabir Madhi discusses South Africa’s susceptibility to a fourth wave, and much more.
ByProgress on getting more HIV patients in South Africa to begin antiretroviral therapy and achieve viral suppression is lagging.
By